Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Tevogen Inc. (TVGN)

Tevogen Director Susan Podlogar Resigns; Board Cut From Six to Five Seats

Neutral Impact 2 of 5 leadership Written later

Tevogen Inc. disclosed that director Susan Podlogar resigned from the board effective immediately on November 2, 2026. The board reduced its size from six to five directors and named current director Lindee Goh to the Audit Committee, both effective the same day.

Key points

  • Susan Podlogar resigned as a director effective November 2, 2026, with notice given that day
  • Board size reduced from six directors to five
  • Lindee Goh, an existing director, appointed to the Audit Committee effective November 2, 2026

The filing

CompanyTevogen Inc. (TVGN)
Form8-K, current report
Filed with the SECNov 4, 2026, 11:50 AM ET
Accession number0001493152-26-049903

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:45 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.